A major update in reproductive healthcare is underway. In May 2026, an international consortium of researchers, clinicians, and patient advocates announced that Polycystic Ovary Syndrome (PCOS) will be renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS). The change was endorsed by the American Society for Reproductive Medicine (ASRM) following a global consensus process involving more than 14,000…